These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 27766882)

  • 1. Salt Disproportionation in the Solid State: Role of Solubility and Counterion Volatility.
    Thakral NK; Behme RJ; Aburub A; Peterson JA; Woods TA; Diseroad BA; Suryanarayanan R; Stephenson GA
    Mol Pharm; 2016 Dec; 13(12):4141-4151. PubMed ID: 27766882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementing quality by design in pharmaceutical salt selection: a modeling approach to understanding disproportionation.
    Merritt JM; Viswanath SK; Stephenson GA
    Pharm Res; 2013 Jan; 30(1):203-17. PubMed ID: 22918819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Excipients on Salt Disproportionation during Dissolution: A Novel Application of In Situ Raman Imaging.
    Abouselo A; Rance GA; Tres F; Taylor LS; Kwokal A; Renou L; Scurr DJ; Burley JC; Aylott JW
    Mol Pharm; 2021 Sep; 18(9):3247-3259. PubMed ID: 34399050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Metallic Stearates on Disproportionation of Hydrochloride Salts of Weak Bases in Solid-State Formulations.
    Nie H; Xu W; Ren J; Taylor LS; Marsac PJ; John CT; Byrn SR
    Mol Pharm; 2016 Oct; 13(10):3541-3552. PubMed ID: 27542728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salt disproportionation: A material science perspective.
    Thakral NK; Kelly RC
    Int J Pharm; 2017 Mar; 520(1-2):228-240. PubMed ID: 28163222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystalline solid dispersion-a strategy to slowdown salt disproportionation in solid state formulations during storage and wet granulation.
    Nie H; Xu W; Taylor LS; Marsac PJ; Byrn SR
    Int J Pharm; 2017 Jan; 517(1-2):203-215. PubMed ID: 27979765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the Differences Between Cocrystal and Salt Aqueous Solubilities.
    Cavanagh KL; Maheshwari C; Rodríguez-Hornedo N
    J Pharm Sci; 2018 Jan; 107(1):113-120. PubMed ID: 29097226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disproportionation of Pharmaceutical Salts: pH
    Avdeef A
    Mol Pharm; 2021 Jul; 18(7):2724-2743. PubMed ID: 34142831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Examination of Water Vapor Sorption by Multicomponent Crystalline and Amorphous Solids and Its Effects on Their Solid-State Properties.
    Newman A; Zografi G
    J Pharm Sci; 2019 Mar; 108(3):1061-1080. PubMed ID: 30391302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of Microenvironmental Acidity: A Strategy to Mitigate Salt Disproportionation in Drug Product Environment.
    Koranne S; Lalge R; Suryanarayanan R
    Mol Pharm; 2020 Apr; 17(4):1324-1334. PubMed ID: 32142293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulating weakly basic HCl salts: relative ability of common excipients to induce disproportionation and the unique deleterious effects of magnesium stearate.
    John CT; Xu W; Lupton LK; Harmon PA
    Pharm Res; 2013 Jun; 30(6):1628-41. PubMed ID: 23512680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of counterion on the chemical stability of crystalline salts of procaine.
    Guerrieri P; Jarring K; Taylor LS
    J Pharm Sci; 2010 Sep; 99(9):3719-30. PubMed ID: 19967781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Solid-State Form on the Disproportionation of Miconazole Mesylate.
    Patel MA; Luthra S; Shamblin SL; Arora K; Krzyzaniak JF; Taylor LS
    Mol Pharm; 2018 Jan; 15(1):40-52. PubMed ID: 29202237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API.
    McNamara DP; Childs SL; Giordano J; Iarriccio A; Cassidy J; Shet MS; Mannion R; O'Donnell E; Park A
    Pharm Res; 2006 Aug; 23(8):1888-97. PubMed ID: 16832611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of In-Situ-Generated Moisture on Disproportionation of Pharmaceutical Salt.
    Weldeab AO; McElderry JD; Lin Y
    Mol Pharm; 2023 Jan; 20(1):561-571. PubMed ID: 36524757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of pharmaceutical salts in solid oral dosage forms.
    Nie H; Byrn SR; Zhou QT
    Drug Dev Ind Pharm; 2017 Aug; 43(8):1215-1228. PubMed ID: 28276282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of excipient properties, water activity, and water content on the disproportionation of a pharmaceutical salt.
    Patel MA; Luthra S; Shamblin SL; Arora KK; Krzyzaniak JF; Taylor LS
    Int J Pharm; 2018 Jul; 546(1-2):226-234. PubMed ID: 29772284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative Salt Selection and Formulation Optimization: Perspectives of Disproportionation and Microenvironmental pH Modulation.
    Mohan S; Li Y; Chu K; De La Paz L; Sperger D; Shi B; Foti C; Rucker V; Lai C
    Mol Pharm; 2024 May; 21(5):2590-2605. PubMed ID: 38656981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantifying Disproportionation in Pharmaceutical Formulations with
    Hirsh DA; Su Y; Nie H; Xu W; Stueber D; Variankaval N; Schurko RW
    Mol Pharm; 2018 Sep; 15(9):4038-4048. PubMed ID: 30016112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case study where pharmaceutical salts were used to address the issue of low in vivo exposure.
    Sigfridsson K; Ulvinge ML; Svensson L; Granath AK
    Drug Dev Ind Pharm; 2019 Feb; 45(2):202-211. PubMed ID: 30256689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.